SCHEMBL31423925

SCHEMBL31423925

CC[C@H](Oc1c(-c2cn[nH]c2)ncn2nc(N[C@@H](C)CF)nc12)C1CC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31423981 1.00 MAPK8 (0.31) MAPK8
SCHEMBL31423914 1.00 MAPK8 (0.31) MAPK8
SCHEMBL31423965 0.88 MAPK8 (0.33) MAPK8
SCHEMBL31423988 0.84 MAPK8 (0.32) MAPK8
SCHEMBL31423976 0.84 MAPK8 (0.32) MAPK8
SCHEMBL31423901 0.84 MAPK8 (0.32) MAPK8
SCHEMBL31423908 0.84 MAPK8 (0.32) MAPK8
SCHEMBL31423922 0.83 MAPK8 (0.32) MAPK8
SCHEMBL31423964 0.83 MAPK8 (0.32) MAPK8
SCHEMBL31423882 0.83 MAPK8 (0.32) MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054386-A1 CDK2 INHIBITORS AND USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2025-03-13 WO disclosed